Teva Pharmaceutical Industries TEVA
NYSE TEVA
$36.84 +0.08 (+0.22%)
As of: Sep 9, 2026 · 3:59 PM EDT

Teva Pharmaceutical Industries (TEVA) Net Margin (QoQ) (2009 - 2026)

Analysis

Teva Pharmaceutical Industries (TEVA) Net Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,320.00
Mar 31, 2026 -68.00
Dec 31, 2025 33.00
Sep 30, 2025 291.00
Jun 30, 2025 107.00
Mar 31, 2025 1,514.00
Dec 31, 2024 -41.00
Sep 30, 2024 1,197.00
Jun 30, 2024 -3,463.00
Mar 31, 2024 313.00
Dec 31, 2023 848.00
Sep 30, 2023 2,536.00
Jun 30, 2023 -1,648.00
Mar 31, 2023 2,744.00
Dec 31, 2022 -3,613.00
Sep 30, 2022 912.00
Jun 30, 2022 1,923.00
Mar 31, 2022 -2,289.00
Dec 31, 2021 -1,156.00
Sep 30, 2021 250.00